REBECCA MCDONALD: Open Payments
NPI 1356478689 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 12 payments from 9 companies in 2025. Trend: 2023 $258 · 2024 $205 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $146 |
| TOLMAR, INC. | 2 | $65 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Ferring Pharmaceuticals Inc. | 2 | $50 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Olympus America Inc. | 1 | $24 |
| DENTSPLY IH AB | 1 | $23 |
| Provepharm Inc. | 1 | $17 |
Products named: AMS 700, JATENZO, KEYTRUDA, ADSTILADRIN, PYLARIFY, JELMYTO, iTIND System, LOFRIC.
Industry payments across MD — which companies pay providers there.
